Irhythm Technologies (IRTC) | Stock Overview & Key Data
Irhythm Technologies Performance Comparison
Stock Range
Today's Range
Low: $158.30
High: $163.98
on August 8, 2025
52 Week Range
Low: $55.92
High: $168.32
on October 14, 2024
on August 1, 2025
All-Time High: $286.19 on January 25, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$5.0B
EPS
-2.92
P/E Ratio (TTM)
-43.93
Forward P/E
-84.79
P/B Ratio
48.32
PEG Ratio
-84.79
Div. Yield
N/A
ROE
-91.14%
Beta
1.407
Debt to Equity
708.80
Financial Highlights
Profitability
Gross Margin
71.17%
Operating Margin
-5.71%
Profit Margin
-14.06%
Returns and Earnings
Return on Assets (TTM)
-3.53%
Return on Equity (TTM)
-91.14%
EBITDA
$-47.4M
Net Income (TTM)
$-92.4M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$20.94
Quarterly Revenue Growth (YoY)
26.10%
Quarterly Earnings Growth (YoY)
26.10%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Irhythm Technologies IRTC | 5.01B Mid-cap | -3.92% | 17.73% | 15.69% | 44.75% | 77.21% | 123.27% | 4.68% | -8.36% |
| Abbott Laboratories ABT | 227.88B Mega-cap | 5.50% | 0.70% | 0.22% | 2.27% | 18.38% | 23.52% | 20.45% | 34.29% |
| Boston Scientific BSX | 152.55B Large-cap | -2.15% | 0.71% | -0.15% | -2.86% | 15.39% | 35.39% | 143.68% | 163.41% |
| Penumbra PEN | 9.39B Mid-cap | -1.04% | -2.95% | -16.71% | -7.88% | 0.21% | 41.44% | 39.80% | 2.95% |
| Masimo MASI | 7.86B Mid-cap | -5.99% | -10.85% | -5.76% | -18.88% | -14.14% | 14.08% | -6.24% | -32.40% |
| Globus Medical GMED | 7.15B Mid-cap | 11.42% | 3.62% | -19.06% | -32.88% | -28.33% | -19.88% | -12.03% | 6.93% |
Ownership & Short Interest
Insider Ownership
0.97%
Institutional Ownership
113.90%
Shares Short
2M
Short Ratio
5.55
Short % of Shares Outstanding
8.70%
Average 10-Day Volume
640K
Average 90-Day Volume
500K
Irhythm Technologies Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Irhythm Technologies would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is IRTC's 52-week high and low?
- In the last 52 weeks, Irhythm Technologies reached a high of $168.32 (on August 1, 2025) and a low of $55.92 (on October 14, 2024).
- What is the market cap and P/E ratio for IRTC?
- Curious about Irhythm Technologies's size and valuation? Its market capitalization stands at 5.01B. When it comes to valuation, the P/E ratio (trailing twelve months) is -43.93, and the forward P/E (looking ahead) is -84.79.
- Does IRTC pay dividends? If so, what's the yield?
- As for dividends, Irhythm Technologies isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Irhythm Technologies's main competitors or similar companies to consider before investing?
When looking at Irhythm Technologies, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT227.88B Healthcare Medical Devices 23.52% 20.45% Boston Scientific
BSX152.55B Healthcare Medical Devices 35.39% 143.68% Penumbra
PEN9.39B Healthcare Medical Devices 41.44% 39.80% Masimo
MASI7.86B Healthcare Medical Devices 14.08% -6.24% Globus Medical
GMED7.15B Healthcare Medical Devices -19.88% -12.03% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Irhythm Technologies Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Irhythm Technologies's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -91.14%, the Debt to Equity ratio from the most recent quarter is 708.80, and its Gross Profit Margin stands at 71.17%.
- What is the recent revenue and earnings growth for IRTC?
- Looking at Irhythm Technologies's growth, its revenue over the trailing twelve months (TTM) was $657M. Compared to the same quarter last year (YoY), quarterly revenue grew by 26.10%, and quarterly earnings saw a YoY growth of 26.10%.
- How much of IRTC stock is held by insiders and institutions?
- Wondering who owns Irhythm Technologies stock? Company insiders (like executives and directors) hold about 0.97% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 113.90%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.